Sign in
4

Changes in Ownership

Alkermes plc. Filed Acc 0001520262-26-000004

EVP R&D, Chief Medical Officer sold 5,000 shares at $30.00 ($150,005)

  • EVP R&D, Chief Medical Officer acquired 5,000 shares (option exercise)
  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Hopkinson Craig C. · EVP R&D, Chief Medical Officer

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2026-01-08 Exercise or conversion : show line 1 in the form 10b5-1 +5,000 $19.34 $96,700 66,740 D
2026-01-08 Sale : show line 2 in the form 10b5-1 −5,000 $30.00 $150,005 61,740 D
Open-market sales · 5,000 sh · avg $30.00 · $150,005

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2026-01-08 Exercise or conversion : show line 3 in the form 10b5-1 Employee Stock Option (Right to Buy) −5,000 31,356 D
Loading xslF345X05/form4.xml…